700 related articles for article (PubMed ID: 12364437)
1. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
Kimpimäki T; Kulmala P; Savola K; Kupila A; Korhonen S; Simell T; Ilonen J; Simell O; Knip M
J Clin Endocrinol Metab; 2002 Oct; 87(10):4572-9. PubMed ID: 12364437
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population.
Kukko M; Kimpimäki T; Korhonen S; Kupila A; Simell S; Veijola R; Simell T; Ilonen J; Simell O; Knip M
J Clin Endocrinol Metab; 2005 May; 90(5):2712-7. PubMed ID: 15872335
[TBL] [Abstract][Full Text] [Related]
3. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
[TBL] [Abstract][Full Text] [Related]
4. Short-term exclusive breastfeeding predisposes young children with increased genetic risk of Type I diabetes to progressive beta-cell autoimmunity.
Kimpimäki T; Erkkola M; Korhonen S; Kupila A; Virtanen SM; Ilonen J; Simell O; Knip M
Diabetologia; 2001 Jan; 44(1):63-9. PubMed ID: 11206413
[TBL] [Abstract][Full Text] [Related]
5. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
[TBL] [Abstract][Full Text] [Related]
6. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study.
Kimpimäki T; Kupila A; Hämäläinen AM; Kukko M; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
J Clin Endocrinol Metab; 2001 Oct; 86(10):4782-8. PubMed ID: 11600541
[TBL] [Abstract][Full Text] [Related]
7. Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group.
Kimpimäki T; Kulmala P; Savola K; Vähäsalo P; Reijonen H; Ilonen J; Akerblom HK; Knip M
J Clin Endocrinol Metab; 2000 Mar; 85(3):1126-32. PubMed ID: 10720050
[TBL] [Abstract][Full Text] [Related]
8. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
9. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.
Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984
[TBL] [Abstract][Full Text] [Related]
10. Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk.
Hämäläinen AM; Ronkainen MS; Akerblom HK; Knip M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4249-53. PubMed ID: 11095462
[TBL] [Abstract][Full Text] [Related]
11. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
Andersson C; Kolmodin M; Ivarsson SA; Carlsson A; Forsander G; Lindblad B; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Ortqvist E; Lernmark A; Elding Larsson H; Törn C;
Pediatr Diabetes; 2014 Aug; 15(5):336-44. PubMed ID: 24206368
[TBL] [Abstract][Full Text] [Related]
12. Familial clustering of beta-cell autoimmunity in initially non-diabetic children.
Kukko M; Toivonen A; Kupila A; Korhonen S; Keskinen P; Veijola R; Virtanen SM; Ilonen J; Simell O; Knip M
Diabetes Metab Res Rev; 2006; 22(1):53-8. PubMed ID: 16100734
[TBL] [Abstract][Full Text] [Related]
13. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
[TBL] [Abstract][Full Text] [Related]
14. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood.
Roll U; Christie MR; Füchtenbusch M; Payton MA; Hawkes CJ; Ziegler AG
Diabetes; 1996 Jul; 45(7):967-73. PubMed ID: 8666150
[TBL] [Abstract][Full Text] [Related]
15. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
[TBL] [Abstract][Full Text] [Related]
16. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
[TBL] [Abstract][Full Text] [Related]
18. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
[TBL] [Abstract][Full Text] [Related]
20. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
